FDA watches compounding pharmacies; drugs get safety labels.
S. 3794 — SAFE Drugs Act of 2026 · Filed by Jim Banks (R-IN) · 1 cosponsor · Introduced Feb 5, 2026 · Reported out
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
Compounding pharmacies and doctors must tell the FDA and states about serious drug harm. Pharmacies sending more than 5% of drugs to other states must file yearly reports. All compounded drugs need labels saying they are not FDA-approved. Labels must list a phone number to report problems.
Who it affects
Patients get clear labels on compounded drugs. They can report harm directly to the FDA. Compounding pharmacies and doctors who send drugs to other states must track and report their work.
One thing to notice
Hospital pharmacies do not have to follow these rules. Yet they also compound drugs.
From the analysis of the bill text, linked under Primary records below.
Where it stands
1 cosponsor: 1 Democrats.
- Feb 5, 2026 — Introduced · Congress.gov: “Introduced in Senate”
- Feb 5, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”
- Jul 22, 2026 — Reported out of committee · Congress.gov: “Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
9 groups reported lobbying about this bill. They filed 9 reports from Jun 2026 to Jun 2026.
Those reports show $600,000 in lobbying spending. Each report lists about 3 bills. So that money was not all for this bill.
More groups named this bill than 89% of bills with any report.
Jim Banks, who sponsored the bill, received $546,126 from PACs for the 2026 election.
- Professional Compounding Centers of America — $220,000 in 1 report
- Alliance for Safe Online Pharmacies (asop Global) — $60,000 in 1 report
- Novo Nordisk Inc. — $60,000 in 1 report
- Alliance for Pharmacy Compounding — $50,000 in 1 report
- Eli Lilly & Company — $50,000 in 1 report
Lobbying is legal. These reports show who lobbied about this bill, not what changed.
Words to know
- compounding pharmacies — Pharmacies that mix drugs by hand for specific patients, not mass-made by factories.
- FDA-approved — Checked and allowed by the U.S. Food and Drug Administration, the federal agency that tests drugs.
- compounded drugs — Medicines mixed by hand at a pharmacy for one patient.
- lobbying — Trying to influence lawmakers about a bill. Companies and groups pay people to do this.
- PACs — Groups that collect money and give it to candidates for office.
- sponsored — To sponsor a bill is to introduce it in Congress and put your name on it.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (3,680 characters) on Aug 16, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 14,206 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-09-17.
“FDA watches compounding pharmacies; drugs get safety labels.” QuorumCivic. https://share.quorumcivic.app/bill/119/s3794/simple Report an error